These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12675214)

  • 1. Polymeric micelle drug carrier systems: PEG-PAsp(Dox) and second generation of micellar drugs.
    Nishiyama N; Kataoka K
    Adv Exp Med Biol; 2003; 519():155-77. PubMed ID: 12675214
    [No Abstract]   [Full Text] [Related]  

  • 2. Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery.
    Shuai X; Ai H; Nasongkla N; Kim S; Gao J
    J Control Release; 2004 Aug; 98(3):415-26. PubMed ID: 15312997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the polymer micelle carrier system for doxorubicin.
    Nakanishi T; Fukushima S; Okamoto K; Suzuki M; Matsumura Y; Yokoyama M; Okano T; Sakurai Y; Kataoka K
    J Control Release; 2001 Jul; 74(1-3):295-302. PubMed ID: 11489509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel targeting drug carrier to deliver chemical bonded and physical entrapped anti-tumor drugs.
    Huang L; Song J; Chen B
    Int J Pharm; 2014 May; 466(1-2):52-7. PubMed ID: 24607212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system.
    Wang Y; Yang T; Wang X; Dai W; Wang J; Zhang X; Li Z; Zhang Q
    J Control Release; 2011 Feb; 149(3):299-306. PubMed ID: 21044651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.
    Hu FQ; Zhang YY; You J; Yuan H; Du YZ
    Mol Pharm; 2012 Sep; 9(9):2469-78. PubMed ID: 22827551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
    Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
    J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved therapeutic effect of DOX-PLGA-PEG micelles decorated with bivalent fragment HAb18 F(ab')(2) for hepatocellular carcinoma.
    Jin C; Qian N; Zhao W; Yang W; Bai L; Wu H; Wang M; Song W; Dou K
    Biomacromolecules; 2010 Sep; 11(9):2422-31. PubMed ID: 20831277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeting peptide conjugated pH-responsive micelles as a potential drug carrier for cancer therapy.
    Wu XL; Kim JH; Koo H; Bae SM; Shin H; Kim MS; Lee BH; Park RW; Kim IS; Choi K; Kwon IC; Kim K; Lee DS
    Bioconjug Chem; 2010 Feb; 21(2):208-13. PubMed ID: 20073455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive polypeptide-based reverse micellar hydrogel.
    Dong CM; Chen Y
    J Control Release; 2011 Nov; 152 Suppl 1():e13-4. PubMed ID: 22195800
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of antitumor effect of doxorubicin by its complexation with gamma-cyclodextrin in pegylated liposomes.
    Arima H; Hagiwara Y; Hirayama F; Uekama K
    J Drug Target; 2006 May; 14(4):225-32. PubMed ID: 16777681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral acidic extracellular pH targeting of pH-responsive MPEG-poly(beta-amino ester) block copolymer micelles for cancer therapy.
    Ko J; Park K; Kim YS; Kim MS; Han JK; Kim K; Park RW; Kim IS; Song HK; Lee DS; Kwon IC
    J Control Release; 2007 Nov; 123(2):109-15. PubMed ID: 17894942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature.
    Yang T; Wang Y; Li Z; Dai W; Yin J; Liang L; Ying X; Zhou S; Wang J; Zhang X; Zhang Q
    Nanomedicine; 2012 Jan; 8(1):81-92. PubMed ID: 21664295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving anticancer activity and reducing systemic toxicity of doxorubicin by self-assembled polymeric micelles.
    Gou M; Shi H; Guo G; Men K; Zhang J; Zheng L; Li Z; Luo F; Qian Z; Zhao X; Wei Y
    Nanotechnology; 2011 Mar; 22(9):095102. PubMed ID: 21270494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
    Xiong XB; Ma Z; Lai R; Lavasanifar A
    Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant enhancement of antitumor activity and bioavailability of intracellular pH-sensitive polymeric micelles by folate conjugation.
    Bae Y; Kataoka K
    J Control Release; 2006 Nov; 116(2):e49-50. PubMed ID: 17718965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.